Globally, poor patient adherence has been identified as being a critical public health issue reaching an average of only 50% in developed countries for chronic conditions. Developing nations display a much lower average.
Today, corporate accountability calls for a more patient centric approach beyond the pharmacy counter. Non-adherence can lead to lives lost, unnecessary hospital admissions & increased doctor visits.
Companies operating in the healthcare industry face a multitude of problems associated with the unorthodox use or misuse of medication leading to poor health outcomes & low brand loyalty. These problems may, beyond patient non-compliance, be exacerbated by the physician's lack of knowledge about the drug or even technical problems with the prescription or the reimbursement.
BIOAXIS Healthcare can monitor & analyse the complete journey of the drug once it has left the pharmacy counter & entered the daily lives of patients, collect related chain information, gather data from patients as well as physicians & make a complete proposal including, if needed, any return on Investment metrics.